Web-based questionnaire survey for the consciousness of patients and doctors about the discontinuation of dyslipidemia treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1080224546

Enrollment

2051

Registered

2019-02-04

Start date

2019-02-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

investigational material(s) Generic name etc : Dyslipidemia Therapeutic Agent INN of investigational material : - Therapeutic category code : 218 Agents for hyperlipidemias Dosage and Administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: [Physician survey] 1.Treat 50 patients with dyslipidemia per month 2.Finish a doctor-in-training [Patient survey] 1.Over 20 years old dyslipidemia patients 2.Have visited a medical institution for the treatment of dyslipidemia within the past 1 year 3.Have been prescribed oral dyslipidemia medications 4.Not a healthcare provider

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
other [Survey in physician] Characteristics (Including screening item): 10 questions [Survey in patient] Characteristics (Including screening item): 6 questions Timeframe: 12 days other [Survey in physician] Measurement item: 20 questions [Survey in patient] Measurement item:30 questions Timeframe: 12 days	—

Secondary

Measure	Time frame
other -	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026